Protagonist Therapeutics Inc. PTGX
Super Investor & Insider
1
Fondi che lo detengono
#1233
Rank consenso
1.4%
% dei portafogli
$2.6M
Valore detenuto
| Fondo | % portaf. | Attività | Azioni | Valore |
|---|---|---|---|---|
| Polen Capital Management · Polen Capital Management | 0.02% | Add 19.6% | 24,337 | $2.6M |
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Protagonist Therapeutics Inc. is a clinical-stage biopharmaceutical company specializing in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company targets unmet medical needs in areas such as hematology, blood disorders, inflammation, immunology, and metabolic…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees128
TickerPTGX
Statistics
Market Cap$7.16B
Revenue (TTM)$46.0M
Net Income-$130.1M
Net Margin-282.8%
EPS$-2.05
P/E139.52
P/S93.47
P/B10.55
EV/EBITDA-44.47
ROE-17.1%
Dividend Yield—
Price$111.53
Data: Twelve Data · Revenue = mcap / P/S